Blocking TLR-4/mitogen activated protein kinase (MAPK) or TLR-4/nuclear factor kappa B (NF-κB) signals successfully reduces HCC-SN-induced B-cell lymphoma 6 (BCL6) upregulation and subsequent PD-1 expression14. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.